Abcam (ABC)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,151.00p
   
  • Change Today:
      41.00p
  • 52 Week High: 1,750.00
  • 52 Week Low: 1,049.00
  • Currency: UK Pounds
  • Shares Issued: 228.94m
  • Volume: 339,168
  • Market Cap: £2,635.11m
  • RiskGrade: 134

Regulatory News

Result of AGM 18-May-2022 16:30 RNS
Director/PDMR Shareholding 03-May-2022 12:41 RNS
Total Voting Rights 29-Apr-2022 16:01 RNS
Director/PDMR Shareholding 05-Apr-2022 16:35 RNS
Publication of 2021 ARA and Notice of AGM 04-Apr-2022 07:00 RNS
Total Voting Rights 31-Mar-2022 10:58 RNS
Block listing Interim Review 30-Mar-2022 14:41 RNS
Block Listing application of Ordinary Shares 28-Mar-2022 15:09 RNS
Director/PDMR Shareholding Notification 17-Mar-2022 13:18 RNS
Results for the period ended 31 December 2021 14-Mar-2022 12:00 RNS
Total Voting Rights 02-Mar-2022 07:00 RNS
Notice of Full Year Results 28-Feb-2022 07:00 RNS
Director/PDMR Shareholding 04-Feb-2022 12:02 RNS
Total Voting Rights 31-Jan-2022 11:49 RNS
Trading Statement 27-Jan-2022 12:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Abcam Market Data

Currency UK Pounds
Share Price 1,151.00p
Change Today 41.00p
% Change 3.69 %
52 Week High 1,750.00
52 Week Low 1,049.00
Volume 339,168
Shares Issued 228.94m
Market Cap £2,635.11m
RiskGrade 134

Abcam Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.66% below the market average92.66% below the market average92.66% below the market average92.66% below the market average92.66% below the market average
92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average
Price Trend
62.9% below the market average62.9% below the market average62.9% below the market average62.9% below the market average62.9% below the market average
4.76% above the sector average4.76% above the sector average4.76% above the sector average4.76% above the sector average4.76% above the sector average
Income
97.19% below the market average97.19% below the market average97.19% below the market average97.19% below the market average97.19% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
96.75% above the market average96.75% above the market average96.75% above the market average96.75% above the market average96.75% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 8
Sell 0
Strong Sell 0
Total 13
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Abcam Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Mar-20 07-Nov-19
Paid 17-Apr-20 29-Nov-19
Amount 3.55p 8.58p

Trades for 20-May-2022

Time Volume / Share Price
16:35 64,482 @ 1,151.00p
16:29 17 @ 1,160.00p
16:29 67 @ 1,160.00p
16:29 8 @ 1,160.00p
16:29 15 @ 1,158.00p

Abcam Key Personnel

CEO Alan Thomas Hirzel
CFO Michael Baldock

Top of Page